Who Paid My Doc
Flublok Quadrivalent Northern Hemisphere
Biological Vaccines
NDC 49281-721-10
General payments
$69,363
Research payments
$2,957,236
Through program year 2021, $69,363 in general payments and $2,957,236 in research payments were reported against Flublok Quadrivalent Northern Hemisphere (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $69,363 | 2,013 |
| 2021 | Research | $2,957,236 | 37 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
2,013 general · 37 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.